Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agents.
İrfan ÇapanMohammed HawashMohammed T QaoudLevent GülümEzgi Nurdan Yenilmez TunogluKezban Uçar ÇifciBekir Sıtkı ÇevrimliYusuf SertSüleyman Serviİrfan KocaYusuf TutarPublished in: BMC chemistry (2024)
values of 2.02 and 4.99 µM, respectively. Compound 4o, in particular, exhibited promising activity by targeting the PI3K/Akt/mTOR signaling pathway, inhibiting tumor survival, inducing apoptosis, and causing cell cycle arrest in MCF-7 cell lines. Furthermore, compound 4o was showed significant antimicrobial activities against S. aureus and E. coli, and antifungal effect against C. albicans. Its potential to overcome drug resistance through this pathway inhibition highlights its promise as an anticancer agent. Molecular docking simulations supported these findings, revealing favorable binding profiles and interactions within the active sites of the enzymes PI3K, AKT1, and mTOR. Moreover, assessing the druggability of the newly synthesized thiosemicarbazide derivatives demonstrated optimal physicochemical properties, further endorsing their potential as drug candidates.
Keyphrases
- cell cycle arrest
- pi k akt
- signaling pathway
- molecular docking
- candida albicans
- cell proliferation
- staphylococcus aureus
- molecular dynamics simulations
- induced apoptosis
- epithelial mesenchymal transition
- escherichia coli
- oxidative stress
- molecular dynamics
- cell death
- breast cancer cells
- big data
- fluorescent probe
- anti inflammatory
- machine learning
- human health
- dna binding
- tissue engineering
- drug induced
- deep learning
- artificial intelligence
- risk assessment
- endoplasmic reticulum stress